Sort
23,748 grants matching “melanoma”
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
$690,941Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · HG
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$690,908Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
$690,825Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2025 · CA
Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
$690,825Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2024 · CA
Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention
$690,676David B Buller · Klein Buendel, Inc. · R01 · FY2014 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$690,624Edgar G. Engleman · Stanford University · R01 · FY2024 · CA
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
$689,934Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$689,820David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Controlling the flux of sphingosine-1-phosphate in vivo
$689,812Kevin R Lynch · University Of Virginia · R01 · FY2020 · AI
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
$689,468Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2023 · AI
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2021 · AI
Controlling the flux of sphingosine-1-phosphate in vivo
$689,462Kevin R Lynch · University Of Virginia · R01 · FY2022 · AI
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
$689,321Jane Amanda Skok · New York University School Of Medicine · R01 · FY2023 · CA
Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention
$689,190David B Buller · Klein Buendel, Inc. · R01 · FY2015 · CA
ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM
$689,125Ronald Walter · Texas State University · R24 · FY2013 · OD
Hyperspectral Imaging-Based Multimode Dermoscope For Early Melanoma Detection
$689,076Daniel L Farkas · Spectral Molecular Imaging, Inc. · R44 · FY2015 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$688,917Kathryn Miller-Jensen · Yale University · U01 · FY2021 · CA
Ultrasound imaging and local drug delivery in tumors
$688,753Katherine W Ferrara · University Of California At Davis · R01 · FY2012 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$688,740Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
UNIVERSITY OF PENNSYLVANIA CANCER GENETICS NETWORK
$688,573University Of Pennsylvania · U24 · FY2000 · CA
Prospective study of cutaneous viral infections and non-melanoma skin cancer
$688,262Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Harnessing the power of genetic relatedness for disease gene discovery
$688,093Jennifer Below · Vanderbilt University Medical Center · R01 · FY2019 · GM
Role of GPNMB in cardiac remodeling
$687,953Arjun Deb · University Of California Los Angeles · R01 · FY2023 · HL
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
$687,888Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2006 · CA